CONFO

What this means for you

Not registered yet, but its 21 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97685859

Mark type

Stylized text

Filed

21 Nov 2022

Published for opposition

21 Apr 2026

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 001 — Chemicals: Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)
• Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for use in oncology and in the field of immunology, namely, pharmaceutical and veterinary preparations for treating immune-related diseases; pharmaceutical and veterinary preparations for the treatment of inflammatory diseases and infections and for the treatment of gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for diagnostic purposes for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, antibody reagents used for the detection of antigens in cells and tissue for medical purposes; veterinary products, namely, antibody reagents for therapeutic use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, small molecules in the form of low molecular weight organic compounds; veterinary products, namely, biological preparations for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan disease
• Class 042 — Scientific and technological services: Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); Design of computer databases; Updating of database software; Data warehousing; Provision of information and data relating to medical research and development; Rendering of computer graphics featuring digital image correction for research and development; Computer graphic design services featuring data and image processing services for making three dimensional models; Non-medical graphic design featuring digital imaging services; Optical imaging for use in research and development of medicines; Imaging via computers for use in research and development of medicines; Graphic design services for generating and processing data and images for making three dimensional models for use in research and development of medicines

Owner

• CONFO THERAPEUTICS NV, ZWIJNAARDE, BE
• Confo Therapeutics N.V., Zwijnaarde, BE
• Confo Therapeutics N.V., Zwijnaarde, BE

Prior registrations

• Registration 4962136

Prosecution history

• 03 Apr 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
• 25 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 03 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 03 Feb 2026 — NON-FINAL ACTION E-MAILED
• 03 Feb 2026 — NON-FINAL ACTION WRITTEN
• 02 Feb 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
• 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 06 Feb 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
• 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 07 Jan 2025 — PUBLISHED FOR OPPOSITION
• 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 11 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER